Neutrophil cytosol factor 2 is a protein that in humans is encoded by the NCF2gene.
Function
This gene encodes neutrophil cytosolic factor 2, the 67-kilodalton cytosolic subunit of the multi-protein complex known as NADPH oxidase found in neutrophils. This oxidase produces a burst of superoxide which is delivered to the lumen of the neutrophil phagosome. Mutations in this gene, as well as in other NADPH oxidase subunits, can result in chronic granulomatous disease.[1]
DeLeo FR, Quinn MT (December 1996). "Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins". Journal of Leukocyte Biology. 60 (6): 677–91. PMID8975869.
Dorseuil O, Gacon G (1997). "[Signal transduction by Rac small G proteins in phagocytes]". Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales. 191 (2): 237–46. PMID9255350.
Leto TL, Lomax KJ, Volpp BD, Nunoi H, Sechler JM, Nauseef WM, Clark RA, Gallin JI, Malech HL (May 1990). "Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src". Science. 248 (4956): 727–30. doi:10.1126/science.1692159. PMID1692159.
Kenney RT, Malech HL, Epstein ND, Roberts RL, Leto TL (December 1993). "Characterization of the p67phox gene: genomic organization and restriction fragment length polymorphism analysis for prenatal diagnosis in chronic granulomatous disease". Blood. 82 (12): 3739–44. PMID7903171.
de Boer M, Hilarius-Stokman PM, Hossle JP, Verhoeven AJ, Graf N, Kenney RT, Seger R, Roos D (January 1994). "Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers". Blood. 83 (2): 531–6. PMID8286749.
Bonaldo MF, Lennon G, Soares MB (September 1996). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Research. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID8889548.
Bonizzato A, Russo MP, Donini M, Dusi S (February 1997). "Identification of a double mutation (D160V-K161E) in the p67phox gene of a chronic granulomatous disease patient". Biochemical and Biophysical Research Communications. 231 (3): 861–3. doi:10.1006/bbrc.1997.6204. PMID9070911.
Sathyamoorthy M, de Mendez I, Adams AG, Leto TL (April 1997). "p40(phox) down-regulates NADPH oxidase activity through interactions with its SH3 domain". The Journal of Biological Chemistry. 272 (14): 9141–6. doi:10.1074/jbc.272.14.9141. PMID9083043.
Ahmed S, Prigmore E, Govind S, Veryard C, Kozma R, Wientjes FB, Segal AW, Lim L (June 1998). "Cryptic Rac-binding and p21(Cdc42Hs/Rac)-activated kinase phosphorylation sites of NADPH oxidase component p67(phox)". The Journal of Biological Chemistry. 273 (25): 15693–701. doi:10.1074/jbc.273.25.15693. PMID9624165.
Faris SL, Rinckel LA, Huang J, Hong YR, Kleinberg ME (June 1998). "Phagocyte NADPH oxidase p67-phox possesses a novel carboxylterminal binding site for the GTPases Rac2 and Cdc42". Biochemical and Biophysical Research Communications. 247 (2): 271–6. doi:10.1006/bbrc.1998.8775. PMID9642115.
Rinckel LA, Faris SL, Hitt ND, Kleinberg ME (September 1999). "Rac1 disrupts p67phox/p40phox binding: a novel role for Rac in NADPH oxidase activation". Biochemical and Biophysical Research Communications. 263 (1): 118–22. doi:10.1006/bbrc.1999.1334. PMID10486263.
Patiño PJ, Rae J, Noack D, Erickson R, Ding J, de Olarte DG, Curnutte JT (October 1999). "Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox". Blood. 94 (7): 2505–14. PMID10498624.
1hh8: THE ACTIVE N-TERMINAL REGION OF P67PHOX: STRUCTURE AT 1.8 ANGSTROM RESOLUTION AND BIOCHEMICAL CHARACTERIZATIONS OF THE A128V MUTANT IMPLICATED IN CHRONIC GRANULOMATOUS DISEASE